Pediatrix Medical Group (MD) Stock Price, News & Analysis

Company Overview

Pediatrix Medical Group, Inc. (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings. Pediatrix partners with hospitals, health systems and other healthcare providers across the United States to manage patient care programs, optimize clinical outcomes and support operational efficiencies. The company’s telehealth initiatives extend critical care expertise to remote and underserved locations while its research division advances evidence-based practices in neonatal and maternal-fetal medicine.

Under the leadership of President and CEO David R. Anderson, Pediatrix Medical Group emphasizes clinical quality, patient safety and physician engagement. The group supports more than 3,500 physicians and advanced practice clinicians and collaborates with over 1,300 facilities nationwide. Pediatrix continues to invest in clinical education, data analytics and population health management to meet the evolving needs of mothers, newborns and pediatric patients.

Key Stats

• Today's Range: $16.25 to $16.59
• 50-Day Range: $11.98 to $17.20
• 52-Week Range: $10.39 to $17.67
• Volume: 193,438 shs
• Average Volume: 751,230 shs
• Market Capitalization: $1.43 billion
• P/E Ratio: 12.79
• Dividend Yield: N/A
• Price Target: $16.79
• Consensus Rating: Moderate Buy

Pediatrix Medical Group Stock Analysis - MarketRank™

Pediatrix Medical Group scored higher than 45% of companies evaluated by MarketBeat, and ranked 669th out of 958 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.1 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Pediatrix Medical Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 5 hold ratings, and no sell ratings.

Upside/Downside

The consensus price target for Pediatrix Medical Group is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Pediatrix Medical Group has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: -2.90%

Earnings Growth

Earnings for Pediatrix Medical Group are expected to decrease by -2.90% in the coming year, from $1.38 to $1.34 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Pediatrix Medical Group is 12.68, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 281.49.

Price to Earnings Ratio vs. Sector

The P/E ratio of Pediatrix Medical Group is 12.68, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 76.34.

Price to Book Value per Share Ratio

Pediatrix Medical Group has a P/B Ratio of 1.84. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.26% of the float of Pediatrix Medical Group has been sold short.

Short Interest Ratio / Days to Cover

Pediatrix Medical Group has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Pediatrix Medical Group has recently decreased by 5.39%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Pediatrix Medical Group does not currently pay a dividend.

Dividend Growth

Pediatrix Medical Group does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

2.26% of the float of Pediatrix Medical Group has been sold short.

Short Interest Ratio / Days to Cover

Pediatrix Medical Group has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Pediatrix Medical Group has recently decreased by 5.39%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.92

News Sentiment

Pediatrix Medical Group has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Pediatrix Medical Group this week, compared to 4 articles on an average week.

Search Interest

12 people have searched for MD on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Pediatrix Medical Group to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Pediatrix Medical Group insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.90% of the stock of Pediatrix Medical Group is held by insiders.

Percentage Held by Institutions

97.71% of the stock of Pediatrix Medical Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

MD Stock Analysis - Frequently Asked Questions

How have MD shares performed this year?

Pediatrix Medical Group's stock was trading at $13.12 at the beginning of the year. Since then, MD stock has increased by 24.8% and is now trading at $16.37.

How were Pediatrix Medical Group's earnings last quarter?

Pediatrix Medical Group, Inc. (NYSE:MD) released its quarterly earnings results on Tuesday, August, 5th. The company reported $0.53 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.42 by $0.11. Pediatrix Medical Group's revenue for the quarter was down 7.1% on a year-over-year basis.
Read the conference call transcript.

Who are Pediatrix Medical Group's major shareholders?

Top institutional investors of Pediatrix Medical Group include Geode Capital Management LLC (2.33%), American Century Companies Inc. (2.22%), Alliancebernstein L.P. (2.11%) and Boston Partners (1.63%). Insiders that own company stock include C Marc Richards, James D Swift, Mark S Ordan, Mary Ann E Moore, Laura A Linynsky and Shirley A Weis.
View institutional ownership trends.

How do I buy shares of Pediatrix Medical Group?

Shares of MD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Pediatrix Medical Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Pediatrix Medical Group investors own include Meta Platforms (META), Tesla (TSLA), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Netflix (NFLX), Advanced Micro Devices (AMD) and Home Depot (HD).

Company Calendar

• Last Earnings: 8/05/2025
• Today: 9/17/2025
• Next Earnings (Estimated): 11/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Health Care Services
• Current Symbol: NYSE:MD
• Previous Symbol: NYSE:PDX
• CIK: 893949
• Web: www.mednax.com
• Phone: (954) 384-0175
• Fax: 954-838-9961
• Employees: 4,305
• Year Founded: 1979

Price Target and Rating

• Average Price Target for Pediatrix Medical Group: $16.79
• High Price Target: $20.00
• Low Price Target: $15.00
• Potential Upside/Downside: +2.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.29
• Trailing P/E Ratio: 12.65
• Forward P/E Ratio: 11.83
• P/E Growth: N/A
• Net Income: -$99.07 million
• Net Margins: 5.66%
• Pretax Margin: 7.30%
• Return on Equity: 18.94%
• Return on Assets: 7.10%

Debt

• Debt-to-Equity Ratio: 0.70
• Current Ratio: 1.80
• Quick Ratio: 1.80

Sales & Book Value

• Annual Sales: $2.01 billion
• Price / Sales: 0.71
• Cash Flow: $1.74 per share
• Price / Cash Flow: 9.40
• Book Value: $8.91 per share
• Price / Book: 1.83

Miscellaneous

• Outstanding Shares: 87,080,000
• Free Float: 86,300,000
• Market Cap: $1.42 billion
• Optionable: Optionable
• Beta: 1.30